School of Medicine


Showing 31-40 of 64 Results

  • Byrne Lee, MD FACS

    Byrne Lee, MD FACS

    Clinical Professor, Surgery - General Surgery

    BioDr. Lee is a native of New York City. He attended the Sophie Davis School of Biomedical Education at the City College of New York and received his medical degree from New York Medical College. He completed general surgery residency training at Lenox Hill Hospital and fellowship training in surgical oncology at the City of Hope National Cancer Center. Dr. Lee led the Peritoneal Surface Malignancy Program at City of Hope prior to joining Stanford in 2019.

    Dr. Lee is a surgical oncologist who specializes in the treatment of gastrointestinal malignancies. He has dedicated his clinical practice to the surgical management of metastatic disease, particularly to the liver and peritoneum. He has expertise in delivering regional cancer therapies such as heated intraperitoneal chemotherapy (HIPEC). Additionally, he performs surgery for cancers of the stomach, liver, pancreas, small intestine, colon, and soft tissue sarcoma. He utilizes minimally invasive and robotic surgical techniques when appropriate.

    Dr. Lee leads the Regional Cancer Therapies program at Stanford. The program implements and develops novel treatment strategies for patients affected with peritoneal malignancies and oligometastatic disease to the liver. His research focus is on clinical outcomes of multidisciplinary management for gastric, hepatobiliary, and peritoneal surface malignancies. He is a member of a national consensus group performing collaborative research and developing clinical trials for HIPEC surgeries.

  • Cara A. Liebert, MD, FACS

    Cara A. Liebert, MD, FACS

    Clinical Assistant Professor, Surgery - General Surgery

    Current Research and Scholarly InterestsCurrent research interests include Surgical Education and Minimally Invasive Surgery. Primary research focus is the development, implementation, and collection of validity evidence for ENTRUST, an online virtual patient simulation platform for assessment of clinical decision-making.

  • Dana Lin, MD

    Dana Lin, MD

    Clinical Associate Professor, Surgery - General Surgery

    BioDr. Lin is a fellowship-trained endocrine surgeon who specializes in surgery of the thyroid, parathyroid, and adrenal glands. After receiving her undergraduate degree from Stanford University, Dr. Lin pursued her medical and surgical training on the east coast, where she completed her residency in general surgery at Rutgers Robert Wood Johnson Medical School and fellowship in endocrine surgery at the Harvard-affiliated Massachusetts General Hospital.

    Dr. Lin's clinical practice focuses on the surgical management of benign and malignant thyroid conditions, hyperparathyroidism, adrenal tumors, as well as melanoma and advanced skin cancers. She is skilled in mini-incision, minimally invasive (laparoscopic), and remote access (scarless endoscopic) surgery as well as lymph node dissection for cancer. She currently serves as Director of the Parathyroid Center within the Endocrine Oncology Program at Stanford.

    Dr. Lin strives to deliver expert surgical care to patients with utmost humanism and compassion. She considers it a privilege and joy to be entrusted as one’s surgeon and is committed to ensuring the best clinical and cosmetic outcome for each of her patients. Dr. Lin welcomes patients at Stanford Cancer Center in Palo Alto as well as Stanford Health Care in Emeryville and Pleasanton (ValleyCare).

  • Daphne P. Ly, MD, FACS

    Daphne P. Ly, MD, FACS

    Affiliate

    Current Research and Scholarly Interests1. Integrate machine learning with electronic health record system to improve work flow and achieve individualize cancer care based on current evidence.
    2. Apply Cancer Genetics in cancer treatment and cancer risk reduction.

  • Paul M. Maggio, MD, MBA, FACS

    Paul M. Maggio, MD, MBA, FACS

    Clinical Professor, Surgery - General Surgery

    BioDr. Paul Maggio is a Professor of Surgery, Chief Quality Officer for Stanford Health Care, and Associate Dean for Quality and Clinical Affairs in the Stanford School of Medicine. He trained in General Surgery at Brown University and obtained advanced training in Adult Surgical Critical Care and Trauma at the University of Michigan. He holds a Master of Business Administration from the University of Michigan and is triple board certified in General Surgery, Critical Care, and Medical Informatics. His clinical focus is on Acute Care Surgery and Critical Care Medicine, and his academic career has been centered on quality improvement, patient safety, and the application of systems engineering to enhance the delivery of healthcare.

    Dr. Maggio participates in the National Committee on Healthcare Engineering for the American College of Surgeons and has served on the Baldrige Board of Examiners to recognize organizations with the highest presidential honor for performance excellence. Dr. Maggio received the SHC Board of Hospital Director’s Denise O’Leary Award for Clinical Excellence in 2013

  • Arden Morris, MD, MPH, FACS

    Arden Morris, MD, MPH, FACS

    Robert L. and Mary Ellenburg Professor of Surgery, and Professor, by courtesy, of Health Policy

    BioArden M. Morris, MD, MPH is Professor of Surgery and Vice-Chair for Clinical Research in the Stanford Department of Surgery. She is Director of the S-SPIRE Center, a health services research collaborative to study patient-centered care, clinical optimization, and health care economics. In her own work, Dr. Morris uses quantitative, qualitative, and mixed research methods to focus on quality of and equity in cancer care. To that end, she currently is funded by American Cancer Society and NIH to study access to care, clinical outcomes, and policy related to insurance design. Dr. Morris currently serves as Vice Chair of the American College of Surgeons Surgical Research Committee, the American Society of Colon and Rectal Surgeons’ representative to the American Joint Commission on Cancer, and Associate Editor for Surgery at JAMA Network Open.

  • Aussama Nassar, MD, MSc,FACS, FRCSC

    Aussama Nassar, MD, MSc,FACS, FRCSC

    Clinical Associate Professor, Surgery - General Surgery

    BioDr. Nassar is board-certified in both General Surgery and Surgical Critical Care in the United States and Canada, underscoring his exceptional expertise in these fields. He holds a Master of Science in Health Science Education from McMaster University, Canada, further solidifying his strong academic foundation.

    Currently, Dr. Nassar serves as the inaugural Director of the Emergency General Surgery Service and the Director of the Surgical Critical Care Fellowship Program at Stanford University. He is also the founder and director of the Surgery Resident Coaching Program. With over 12 years of clinical and academic experience at premier tertiary care referral centers across North America, Dr. Nassar brings unparalleled knowledge and leadership to his roles.

    Dr. Nassar's clinical interests include trauma, acute care surgery, critical care, and a particular focus on abdominal wall reconstruction. As a dedicated clinician-educator, he is a certified simulation educator and serves as a course director for ATLS and ASSET programs. His research is centered on advancing surgical education, with an emphasis on fostering the development of non-technical skills in surgical training.

    In addition to his educational initiatives, Dr. Nassar is actively engaged in developing innovative assessment tools for surgical trainees and addressing burnout among physicians and healthcare professionals. With a strong national and international presence, Dr. Nassar continues to shape the future of surgical education and healthcare delivery through his leadership, research, and advocacy.

  • Jeffrey Norton, MD

    Jeffrey Norton, MD

    Robert L. and Mary Ellenburg Professor of Surgery, Emeritus

    Current Research and Scholarly InterestsInterleukin-12 is a Th1 cytokine. It is important in the cell mediated immune response. We are investigating its role as an anti-tumor cytokine to augment the immune response against cancer. We are planning a human trial.